Advertisement

Topics

Scotland Greenlights More Rare Disease Treatments

09:57 EDT 13 Jun 2019 | Elsevier Business Intelligence

Scotland’s health technology appraisal body has OKd Alynlam’s Onpattro, AstraZeneca's Imfinzi and Takeda’...

Original Article: Scotland Greenlights More Rare Disease Treatments

NEXT ARTICLE

More From BioPortfolio on "Scotland Greenlights More Rare Disease Treatments"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...